NCT01474980

Brief Summary

This is a retrospective study that follows the clinical evolution, the pregnancy and the post-partum perioad of female patients with Congenital Myasthenic Syndrome.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2010

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 16, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 18, 2011

Completed
Last Updated

November 18, 2011

Status Verified

November 1, 2011

Enrollment Period

1 year

First QC Date

November 16, 2011

Last Update Submit

November 17, 2011

Conditions

Congenital Myasthenic Syndrome

Keywords

Congenital Myasthenic SyndromePregnancyOutcome

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women with Congenital Myasthenie Syndrome

You may qualify if:

  • Adult women
  • Congenital myastenic syndrome genetically confirmed or with clinical compatible and electrophysiological evidence
  • Written consent

You may not qualify if:

  • Neurological or general pathology occurs significantly with the initiation and conduct of a pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Myasthenic Syndromes, Congenital

Condition Hierarchy (Ancestors)

Neuromuscular Junction DiseasesNeuromuscular DiseasesNervous System DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Laurent SERVAIS, MD, PhD

    institut myologie

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Laurent SERVAIS MD, PhD

Study Record Dates

First Submitted

November 16, 2011

First Posted

November 18, 2011

Study Start

January 1, 2010

Primary Completion

January 1, 2011

Study Completion

October 1, 2011

Last Updated

November 18, 2011

Record last verified: 2011-11